WO2006033351A1 - Composition induisant l'expression de la thioredoxine - Google Patents

Composition induisant l'expression de la thioredoxine Download PDF

Info

Publication number
WO2006033351A1
WO2006033351A1 PCT/JP2005/017383 JP2005017383W WO2006033351A1 WO 2006033351 A1 WO2006033351 A1 WO 2006033351A1 JP 2005017383 W JP2005017383 W JP 2005017383W WO 2006033351 A1 WO2006033351 A1 WO 2006033351A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
thioredoxin
expression
blue
mugwort
Prior art date
Application number
PCT/JP2005/017383
Other languages
English (en)
Japanese (ja)
Inventor
Junji Yodoi
Hiroshi Masutani
Yuji Kunimoto
Koji Takatera
Nobue Kanou
Kazuo Murata
Shogo Tamasu
Original Assignee
Kyoto University
Rock Field Co., Ltd.
Redox Bioscience Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto University, Rock Field Co., Ltd., Redox Bioscience Inc. filed Critical Kyoto University
Priority to JP2006536394A priority Critical patent/JPWO2006033351A1/ja
Publication of WO2006033351A1 publication Critical patent/WO2006033351A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

L'invention concerne une composition induisant l'expression de la thiorédoxine, utile pour limiter les influences du stress oxydant, etc., et qui est sans danger. L'invention procure une composition à utiliser dans les domaines de l'alimentation, des produits pharmaceutiques, de l'alimentation animale, etc., comprenant au moins un ingrédient choisi parmi le groupe constitué de la tanaisie, d'un extrait de tanaisie, de périlla vert et d'un extrait de périlla vert.
PCT/JP2005/017383 2004-09-22 2005-09-21 Composition induisant l'expression de la thioredoxine WO2006033351A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006536394A JPWO2006033351A1 (ja) 2004-09-22 2005-09-21 チオレドキシン発現誘導用組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004-275680 2004-09-22
JP2004275680 2004-09-22

Publications (1)

Publication Number Publication Date
WO2006033351A1 true WO2006033351A1 (fr) 2006-03-30

Family

ID=36090108

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/017383 WO2006033351A1 (fr) 2004-09-22 2005-09-21 Composition induisant l'expression de la thioredoxine

Country Status (2)

Country Link
JP (1) JPWO2006033351A1 (fr)
WO (1) WO2006033351A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007302633A (ja) * 2006-05-12 2007-11-22 Redox Bioscience Inc 繊維質の燃焼時に発生する煙に含まれる有害成分によって引き起こされる障害の予防乃至治療剤
JP2009256256A (ja) * 2008-04-18 2009-11-05 Kyushu Univ 組成物及び飲食品
JP2010537664A (ja) * 2007-10-24 2010-12-09 アールエヌエル バイオ カンパニー リミテッド カワラヨモギを含有する家畜の産乳量増加用組成物
WO2011093469A1 (fr) 2010-01-29 2011-08-04 株式会社資生堂 Promoteur d'expression pour un facteur associé à une réduction-oxydation
CN102961463A (zh) * 2012-11-14 2013-03-13 贵州百灵企业集团制药股份有限公司 一种感清颗粒剂的制备工艺
JP2016006021A (ja) * 2014-06-20 2016-01-14 株式会社ノエビア チオレドキシン関連因子発現促進剤
JP2017057178A (ja) * 2015-09-18 2017-03-23 イビデン株式会社 青ジソ抽出物及び青ジソ抽出物の製造方法
JP2018062481A (ja) * 2016-10-12 2018-04-19 株式会社バスクリン アルブチン含有組成物、及び、アルブチンの分解抑制方法

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Edited by National Agriculture and Bio-oriented Research Organization, National Agricultural Research Center for Kyushu Okinawa Region, Okinawa Nosakumotsu no Kosanka Kassei, Kyushu Okinawa Nogyo Kenkyu Senta ni Okeru Saikin ni Shuyo Kenkyu Seika (Dai 7 Shu Heisei 16 Nen, 3 Gatsu 30 Nichi, page 17", OKINAWA NOSAKUMOTSU NO KOSANKA KASSEI, KYUSHU OKINAWA NOGYOKENKYU SENTA NO OKERU SAIKIN NO SHUYO KENKYU SEIKA, XX, JP, 1 January 1900 (1900-01-01), JP, pages 17, XP002997926 *
ANIYA Y ET AL: "Antioxidant and hepatoprotective actions of the medicinal herb Artemisia campestris from the Okinawa Islands.", BIOL PHARM BULL., vol. 23, no. 3, 2000, pages 309 - 312, XP002997932 *
AZUMA KEIKO.: "Yasai no Kinosei to Chumoku Sareru Kinosei Seibun.", NOKO TO ENGEI, 2004 NEN 9 GATSU 1 NICHI., vol. 59, no. 9, 2004, pages 36 - 39, XP002997933 *
ITO SHIGERU ET AL: "Aojiso Chushutsubutsu no Radical Shokyono Oyobi kosamkaryoku no Anteisei. (Sabillity of the Radical scavenging Activity and the Anti-oxidative Activity of Extracts from Green-Perilla Leaf)", AICHIKEN NOGYO SOGO SHIKENJO KENKYU HOKOKU. RES.BULL.AICHI.AGRIC. RES., no. 34, 2002, pages 111 - 114, XP002997927 *
ITO SHIGERU.: "Aojiso no Shikaku Jiki Riyo Bui to Naiyo Seibun.", SHOKUHIN NO SHIKEN TO KENKYU., no. 37, 2002, pages 66 - 68, XP002997929 *
KURIBAYASHI TSUYOSHI ET AL: "Tokusan Yasai Kakohin no Kosankasei ni Kansuru Kenkyu.", RESEARCH REPORT OF FOOD TECHNOLGY RESEARCH INSTITUTE OF NAGANO PREFECTURE., no. 31, 2003, pages 33 - 36, XP002997928 *
MASUDA KATUMI ET AL: "Seiyaku no Kosankasei ni Kansuru Kenkyu. (Studies on Antioxidative Effects of Crude Drugs)", JINAI JOSHI TANKI DAIGAKU KENKYU KIYO., no. 27, 1996, pages 67 - 72, XP002997908 *
MIURA KAYOKO ET AL: "Ryukyu Yomogi (Artemisa campestris) ni Fukumareru Polyphenol to Kosanka Kassei.", JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, 2004 NENDO (HEISEI 16 NENDO) TAIKAI KOEN YOSHISHU., 5 March 2004 (2004-03-05), pages 89, 2A23P20, XP002997907 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007302633A (ja) * 2006-05-12 2007-11-22 Redox Bioscience Inc 繊維質の燃焼時に発生する煙に含まれる有害成分によって引き起こされる障害の予防乃至治療剤
JP2010537664A (ja) * 2007-10-24 2010-12-09 アールエヌエル バイオ カンパニー リミテッド カワラヨモギを含有する家畜の産乳量増加用組成物
JP2009256256A (ja) * 2008-04-18 2009-11-05 Kyushu Univ 組成物及び飲食品
WO2011093469A1 (fr) 2010-01-29 2011-08-04 株式会社資生堂 Promoteur d'expression pour un facteur associé à une réduction-oxydation
CN102961463A (zh) * 2012-11-14 2013-03-13 贵州百灵企业集团制药股份有限公司 一种感清颗粒剂的制备工艺
JP2016006021A (ja) * 2014-06-20 2016-01-14 株式会社ノエビア チオレドキシン関連因子発現促進剤
JP2017057178A (ja) * 2015-09-18 2017-03-23 イビデン株式会社 青ジソ抽出物及び青ジソ抽出物の製造方法
JP2018062481A (ja) * 2016-10-12 2018-04-19 株式会社バスクリン アルブチン含有組成物、及び、アルブチンの分解抑制方法

Also Published As

Publication number Publication date
JPWO2006033351A1 (ja) 2008-05-15

Similar Documents

Publication Publication Date Title
WO2006033351A1 (fr) Composition induisant l'expression de la thioredoxine
KR20070053762A (ko) 리파아제 저해제
KR101790800B1 (ko) 조 카페인 복합체, 조 카페인 복합체를 사용하는 개선된 식품, 그것의 사용 방법
KR101695848B1 (ko) 진세노사이드 f2를 포함하는 비알코올성 간 질환 또는 인슐린 저항성의 예방 또는 치료용 조성물
WO2007001080A1 (fr) Boisson/aliment et produit pharmaceutique comprenant un extrait de feuille de néflier du japon
JPWO2006135084A1 (ja) 脂肪性肝炎または脂肪肝の予防または治療薬
JP2006109754A (ja) チオレドキシンの発現を誘導する食品
EP3974026A1 (fr) Composition destinée à améliorer la fonction hépatique
KR20210039961A (ko) 건강한 임산부 모유 유래 혐기성 인체 균주 및 이를 이용한 대사성 질환의 예방 또는 치료방법
JP2007513150A (ja) ウリ科植物の抽出物またはウリ科植物の抽出物から単離した精製抽出物から構成される抗脂肪生成および抗肥満活性を有する組成物
JP7229513B2 (ja) 脳の機能改善剤および脳の機能改善用飲食品
JP5619752B2 (ja) パンドラチン誘導体またはボエセンベルギアパンドラタ抽出物の新規な用途
KR101188581B1 (ko) 향부자 메탄올 추출물을 유효성분으로 함유하는 패혈증 예방 또는 치료용 조성물
JPWO2006030907A1 (ja) 網膜保護剤
JP2006008523A (ja) 生理活性フェノール性化合物およびそれを含有してなる食品
JP6131275B2 (ja) Ｉｇｆ−１産生促進剤
JP2013091608A (ja) ミオスタチン／Ｓｍａｄシグナル阻害剤
JP2004161644A (ja) 膵リパーゼ阻害剤及び該阻害剤を含有する食品
AU2010205126A1 (en) Postprandial hyperglycemia-improving agent
KR102573074B1 (ko) 시르투인1 활성화제 및 시르투인1 활성화용 피부 화장료
JP2010254590A (ja) 膵リパーゼ阻害剤
GB2462484A (en) Composition comprising Caralluma fimbriata, Shuddha guggulu, and Triphala extracts
JP2011132147A (ja) 濃縮赤ワインエキスを有効成分とする中性脂肪吸収阻害剤
JP2010095477A (ja) リパーゼ阻害剤
JP6267557B2 (ja) 筋萎縮抑制剤

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006536394

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase